메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

NCCN Guidelines Navigator for Breast Cancer Genetic Testing…

[ 메디채널 김갑성 기자 ] The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for more than a dozen cancer types, along with hereditary risk assessment, featuring seamless integration with additional resources. PLYMOUTH MEETING, Pa., Oct. 6, 2025 -- Today, the National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN Guidelines Navigator™ resources for breast cancer treatment as well as genetic/familia
- 김갑성 기자
- 2025-10-06 21:04
Beacon Global Strategies Announces Dedicated Japan Off…

WASHINGTON, Oct. 6, 2025 -- Beacon Global Strategies (BGS) today announced that Dr. Zack Cooper has joined the firm as a Senior Advisor within its Indo-Pacific Practice. Dr. Cooper will play a central role in advancing BGS's work with Japanese clients and multinational companies with interests in Japan and the broader Indo-Pacific region. A recognized expert on U.S.-Japan relations, allied security cooperation, and the region's economic and geopolitical dynamics, he brings extensive experience advising clients across Tokyo, Washington, and beyond. Dr. Cooper's addition further
- 김갑성 기자
- 2025-10-06 21:00
Beacon Global Strategies 、日本向け専用サービスとザック・クーパー博士の…

ワシントン、2025年10月6日 --Beacon Global Strategies (BGS) は本日、ザック・クーパー博士をインド太平洋プラクティスのシニア・アドバイザーとして迎え入れたことを発表しました。クーパー博士は、BGSが抱える日本のクライアントや、日本およびインド太平洋地域全体に関心を持つ多国籍企業との仕事を推進するうえで、中心的な役割を担うことになります。日米関係や同盟国の安全保障協力、そして地域における経済的・地政学的ダイナミクスの専門家として知られ、東京、ワシントン、その他の地域のクライアントへのアドバイスについて豊富な経験を有しています。戦略的競争とビジネスの不確実性が高まるなか、BGSの能力はクーパー博士の加入によりさらに強化され、とりわけクライアントが同盟関係の力学、地域の発展、進化する経済安全保障政策に対応できるようになります。「中国との戦略的競争が激化し、アジアにおける協力の重要性が見直されるなか、企業はザックがこれまで一貫して提供してきたような地域に関する専門知識を必要としています。今回の彼の加入は、BGSのインド太平洋プラクティスにとって大きな前進であり、当社が持つワシントンと東京の政策決定が交錯するなかで実行可能なアドバイスを提供する能力を強化するものです」と、BGSのマネージング・デ
- 김갑성 기자
- 2025-10-06 21:00
Halia Therapeutics Strengthens Global Genomics Leaders…

New CSO & GM role underscores Halia's commitment to resilience-based therapeutic development and advances collaboration with the Department of Health – Abu Dhabi LEHI, Utah, Oct. 6, 2025 -- Halia Therapeutics (The Genetic Resilience Company), a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced the appointment of Paul Jones as Chief Strategy Officer & GM, International Markets. In this newly created role, Jones will focus on accelerating GENMOR-AI, the company's proprietary platform for identifying genetic mo
- 김갑성 기자
- 2025-10-06 20:15
Olympus and W. L. Gore & Associates Enter into International…

CENTER VALLEY, Pa., and HAMBURG, Germany, Oct. 6, 2025 -- Olympus Corporation, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, has entered into an international distribution agreement with the medical products business of U.S.-based W. L. Gore & Associates, Inc. (hereinafter Gore), a global materials science company that develops innovative products across diverse industries. The agreement allows Olympus to become the exclusive international distributor and have distribution rights of the GORE® VIABIL® Biliar
- 김갑성 기자
- 2025-10-06 15:00
FDA Lifts Clinical Hold on NUZ-001

Highlights: U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 IND supported by robust preclinical safety data and comprehensive manufacturing and quality information from the previously signed Elanco licensing agreement Expedites NUZ-001 as a platform molecule with pipeline expansion potential Positions Neurizon for accelerated regulatory pathways and future partnering opportunities MELBOURNE, Australia, Oct. 6, 2025
- 김갑성 기자
- 2025-10-06 14:06
Taiwan Pavilion Fostering Collaborative Innovation in AI, Rege…

TAIPEI, Oct. 6, 2025 -- The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO), an organization focused on fostering Taiwan's biotech ecosystem, announced today that it will lead a delegation of 16 biotech industry partners from Taiwan to participate in BioJapan 2025 (Yokohama, October 8-10, 2025). Taiwan's participation in BioJapan 2025, through the Taiwan Pavilion and delegation, will serve as an impactful forum to showcase the value that Taiwan's ecosystem can bring to Japanese companies in jointly realizing the future of biotech innovation. BPIPO's Partici
- 김갑성 기자
- 2025-10-06 07:15
Hong Kong Tech Startup Advances AI Lung Cancer Screen…

HONG KONG, Oct. 4, 2025 -- Caretia, a local tech startup based at Hong Kong Science Park, today announced that its AI-powered lung cancer screening platform has achieved initial milestones and entered a new phase of development. This progress aligns closely with the direction set out in the 2025 Policy Address, where Chief Executive Mr. John Lee indicated that the government would comprehensively enhance cancer prevention and diagnosis and specifically recommended launching AI-assisted lung cancer screening. According to data from the HK Cancer Online Resource Hub, lung cancer
- 김갑성 기자
- 2025-10-04 08:00
SI 그룹, 아젤리스와 신규 파트너십 통해 EMEA 지역 유통망 확대

-- 브렌탁과의 오랜 파트너십 보완하는 아젤리스와의 새로운 협력 관계로 SI 그룹의 고객 접근성 확대 기대 더 우드랜즈, 텍사스, 2025년 10월 4일 -- 세계적인 고성능 첨가제, 생산 공정 솔루션, 의약품, 유기화학물 중간체 개발사이자 제조사인 SI 그룹(SI Group)이 2일 유럽·중동·아프리카(EMEA) 지역에서 플라스틱 첨가제 유통망을 확장하기 위해 아젤리스(Azelis)와 새로운 파트너십을 체결했다고 밝혔다. 2026년 1월 1일부터 시작되는 이번 파트너십을 통해 SI 그룹은 영향력을 확대하고 맞춤형 솔루션 및 현지 지원을 통해 고객 서비스 역량을 강화할 예정이다. SI 그룹은 또 신뢰할 수 있는 유통 파트너인 브렌탁(Brenntag)과 2005년부터 이어온 협력을 EMEA 지역 일부 국가에서 계속 이어갈 계획이다. SI 그룹은 아젤리스와 브렌탁이 시장에서 가장 큰 영향력을 발휘할 수 있는 지역에 집중하기 위한 전략적 차원에서 양사와의 파트너십을 결정했다. SI 그룹은 양사의 영업 인력 역량, 기술 전문성, 창고 관리 능력을 활용해 고객의 제품 접근성과 고객 지원 서비스를 강화하
- 김갑성 기자
- 2025-10-03 23:26
Positioning Da Nang as Southeast Asia's Leading Medica…

DA NANG, Vietnam, Oct. 3, 2025 -- Da Nang is set to host the Da Nang Global Business Summit 2025 under the theme "Unlocking the Future of Medical & Wellness Tourism: Innovation – Creativity – Global Connectivity". The two-day event will take place on November 11–12, 2025, at Fusion Resort & Villas Da Nang, affirming the city's ambition to become a leading hub for medical tourism in the region. The summit is expected to welcome over 200 senior leaders and policymakers from international hospitals, technology corporations, tourism enterprises, and government age
- 김갑성 기자
- 2025-10-03 17:37

이전

81 82 83 84 85 86 87 88 89 90

많이 본 기사

최근기사

2025-12-16_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 16일 15시 50분